...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New SEDAR page
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Just searched the Disciplined list for Zenith Capital Corp on SEDAR+ and found that the last action was 7 September 2022. This string could be nothing more than someone not entering data in a timely fashion from either the companies side or the regulators side.

tada 

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply